SharesGrow.com 标普和纳斯达克内在价值联系我们

हिन्दी

← 返回所有股票

Universal American Corporation UAM NYSE

NYSE • Healthcare • Medical - Healthcare Plans • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Universal American Corporation (UAM) 是一家 Medical - Healthcare Plans 公司，属于医疗保健行业, 目前交易价格为 $1.75. 其SharesGrow评分为 39/100, 表明较弱的投资特征， 7项中通过1项.

财务数据: 营收为 $1.4B, -13.3%/yr 平均增长. 净利润为 $55M, 增长率为 -79.3%/yr. 净利润率为 4% (较薄). 毛利率为 16.4% (-6.8 pp 趋势).

资产负债表: 总债务为 $186M 对比 $269M 股东权益 (D/E比率 0.69, 适度). 流动比率为 2.31 (流动性强). 资产负债率为 23.7%. 总资产: $786M.

SharesGrow 7项标准细分: Value 100/100 (Pass), Growth 15/100 (Fail), Past 25/100 (Fail), Health 50/100 (Partial), Moat 19/100 (Fail), Future ?/100 (Fail), Income 30/100 (Fail).

UAM SharesGrow 评分概览

40/100

SharesGrow Score

Mixed signals — some strengths

View full scorecard →

价值 100/100

估值 — P/E, PEG, Forward PEG

成长 15/100

财务数据 — 平均增长

过去 25/100

强劲 — 趋势

健康 50/100

资产负债表 — D/E比率, 流动比率为

护城河 19/100

毛利率为 + market cap

未來 0/100

分析师展望 — 为买入

收入 30/100

净利润率为

Scores derived from financial statements, analyst ratings, and balance sheet data.

评分明细 — UAM

UAM 市盈率(P/E)为 N/A (S&P 500平均约25). Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + 上涨空间 (25%) + trailing PEG (20%). ≥ 60 = Pass.

View details →

UAM: -13.3%/yr 营收为, -79.3%/yr 净利润为平均增长. 较弱. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.

View details →

UAM: 1 / 4 年盈利. 较弱. Score = 1 / 4 × 100. ≥ 80 = Pass.

View details →

资产负债表 UAM: D/E比率 0.69 (适度), 流动比率为 2.31 (流动性强). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.

View details →

UAM: 毛利率为 16.4% (-6.8 pp 趋势), N/A market cap. Moat (0-100): margin (35%) + 趋势 (15%) + market cap (30%) + 营收为 (20%). Score 19/100. ≥ 70 = Pass.

View details →

No analyst coverage available for this stock.

UAM: 净利润率为 4%. 较薄 (0-5%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.

View details →

股票图表与统计

市场数据

52周区间1.85-1.6

30日平均成交量913

Beta（1年）-0.46

股份统计

EPS（TTM）0.78

流通股数$70.67M

IPO日期2019-04-15

财务亮点与比率

营收（TTM）$1.38B

毛利润$225.82M

EBITDA$77.65M

净利润$55.38M

营业利润$-1.94M

现金总额$355.96M

总负债$185.79M

净负债$81.33M

总资产$785.58M

市盈率（P/E）2.2

分析师预测

公司信息

交易所NYSE

货币USD

股价走势

UAM

Universal American Corporation · NYSE

Healthcare • Medical - Healthcare Plans

其他人也在看

Eli Lilly and Company

Johnson & Johnson

Roche Holding AG

Roche Holding AG

AstraZeneca PLC

Merck & Co., Inc.

联系我们

🎓

SharesGrow 学院

学习如何计算内在价值，发现被低估的股票。

每周在线课程

📧 [email protected]

📞 +65 8912 8000

给我们留言